| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |